ArticleJournal of translational medicine2012

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers.

Maggie J Rathos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.